(Z)-beta-Curcumen-12-ol is a sandalwood-linked sesquiterpene alcohol found in Santalum spicatum and related sandalwood compositions, where it functions mainly as a compositional and chemotype marker rather than a well-studied isolated active. The strongest live evidence supports identity, occurrence in Australian and East Indian sandalwood profiles, and population-level variation across sandalwood sources, while direct constituent-specific pharmacology and human safety data remain sparse. AromaForge should present it as a secondary sandalwood identity constituent with clear chemistry value and clearly labeled evidence limits.
Chemical identity and composition
PubChem CID 91710638 maps beta-(Z)-curcumen-12-ol to C15H24O with the stereodescriptive name (Z,6R)-2-methyl-6-(4-methylcyclohexa-1,4-dien-1-yl)hept-2-en-1-ol and synonym CAS 698365-10-5. In the local archive it is substantial in Australian sandalwood records, including 8.6% in the SW0100 Santalum spicatum GC/MS sheet and 5.0% in a 2024 Oshadhi Santalum spicatum chromatographic analysis, supporting its relevance as a real secondary-to-major sandalwood sesquiterpenol rather than a trace curiosity.
Aroma and practical use
- Use the recorded woody, sandalwood, soft, warm descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
identity confirmation in pubchem
PubChem CID 91710638 lists beta-(Z)-curcumen-12-ol as a distinct C15H24O sesquiterpenol with a defined stereochemical name and synonym set, giving this archive constituent firmer identity support than many minor sandalwood peaks.
Measured: compound identity, stereochemical name, and synonym set
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
australian sandalwood occurrence
Two directly readable Santalum spicatum GC reports place (Z)-beta-Curcumen-12-ol at meaningful levels, including 8.6% in the SW0100 report and 5.0% in a 2024 Oshadhi analysis, showing that the compound can be a notable part of Australian sandalwood chemistry.
Measured: quantified abundance in Australian sandalwood
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
sandalwood population variation
A PubMed-indexed population study reported that the Erromango population was unusual because monocyclic sesquiterpenes, specifically (Z)-beta-curcumen-12-ol and cis-nuciferol, exceeded the bi- and tricyclic santalols, illustrating how strongly this constituent can track sandalwood chemotype variation.
Measured: population-level oil composition differences
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Use concerns and concentration limits
Sensitization concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
No numeric constituent-specific use limit is available here. Missing is not an unrestricted-use clearance.
No constituent-specific IFRA limit, human dermal study, or toxicology monograph for isolated (Z)-beta-Curcumen-12-ol was verified in this pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
The reviewed literature supports occurrence and identity much better than standalone pharmacology or safety characterization.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- No isolated-compound human clinical or constituent-specific toxicology literature was verified for (Z)-beta-Curcumen-12-ol; dermal_limit_pct, sensitizing, and phototoxic were corrected from unsourced placeholders to null after a 2026-07-13 verification pass found no supporting citation.
- Mechanism-level claims for the purified constituent remain sparse in the accessible public record.
- Most useful evidence currently comes from compositional and chemotype studies rather than standalone pharmacology.
- No constituent-specific numeric dermal reference is available here.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.